These data underscore the possibility that controlling cell division rate by circadian clock enhancement and thus controlling tumor growth is not restricted to mouse melanoma cells, and may be generally applicable to human cancer cells and to other cancer types. The gene discussed is CLOCK; the disease is cancer.